Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
9 participants
OBSERVATIONAL
2003-01-31
2005-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Report manganese serum levels and mortality in encephalopathic patients.
Patients and participants:
Consecutive patients aged \> 18 years, with hepatic encephalopathy and informed consent signed by their families.
Interventions:
Patients' clinical characteristics as well as biochemical tests of renal function, hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze manganese levels with a graphite furnace atomic absorption spectrometer.
Hypothesis:
There is a difference in the manganese levels between male and female patients.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With hepatic encephalopathy
* Informed consent signed by their families
Exclusion Criteria
* Cancer of any localization
* Known malignancy and other severe diseases which shorten life expectancy \< 6 months
* Psychiatric illness
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General "Dr. Darío Fernández Fierro"
UNKNOWN
National Institute of Neurology and Neurosurgery
UNKNOWN
Materno-Perinatal Hospital of the State of Mexico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Materno-Perinatal Hospital of the State of Mexico
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hugo Mendieta Zerón, PhD
Role: PRINCIPAL_INVESTIGATOR
Materno-Perinatal Hospital of the State of Mexico
Camilo Rios Castañeda, PhD
Role: STUDY_DIRECTOR
National Institute of Neurology and Neurosurgery
Mónica Rodríguez Rodríguez, MD
Role: STUDY_CHAIR
General Hospital "Dr. Darío Fernández Fierro"
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital "Dr. Darío Fernández Fierro"
México, D.f., Mexico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zeron HM, Rodriguez MR, Montes S, Castaneda CR. Blood manganese levels in patients with hepatic encephalopathy. J Trace Elem Med Biol. 2011 Dec;25(4):225-9. doi: 10.1016/j.jtemb.2011.07.003. Epub 2011 Oct 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HGDrDFF-Mn2008
Identifier Type: -
Identifier Source: org_study_id